Back to search

Netherlands· NL-838bbb4b6954

Ezetimibe/Simvastatine Viatris 10 mg/80 mg, tabletten

A simvastatin and ezetimibe product containing ezetimib + simvastatine, registered in Netherlands by Viatris Limited. The same ATC class is registered in 13 of our 19 countries.

ATC C10BA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEzetimibe/Simvastatine Viatris 10 mg/…ATCC10BA02REGISTER NO.NL-838bbb4b6954PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Simvastatin and ezetimibe is registered in 13 of 19 countries.

Countries holding a registration under ATC C10BA02 (simvastatin and ezetimibe), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Simvastatin and ezetimibe · ATC C10BA02

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EZETIMIB + SIMVASTATINE
Manufacturer
Viatris Limited
Country
Netherlands (NL)
ATC code
C10BA02
ATC class
Simvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    115287

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

14 interactions on record for simvastatin and ezetimibe.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Simvastatin and ezetimibe · interactions on record

14 records

14 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Simvastatin and ezetimibe in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Ezesim, Ezetimib/Simvastatin Accord
  • Belgium · Ezetimib/Simvastatin Ab, Ezetimibe/Simvastatin Krka
  • Cyprus · Ezetimibe/Simvastatin Accord, Inegy
  • Czechia · Ezetimibe/Simvastatin Teva Cr, Glezisim
  • Germany · Ezesimin, Ezetimib Simvastatin Zentiva
  • Denmark · Ezetimib/Simvastatin Demo, Ezetimib/Simvastatin Hexal
  • Spain · Ezetimiba/Simvastatina Alter, Ezetimiba/Simvastatina Aurovitas
  • France · Ezetimibe/Simvastatine Accord, Ezetimibe/Simvastatine Almus
  • United Kingdom (Northern Ireland) · Ezetimibe/Simvastatin Accord Healthcare, Ezetimibe/Simvastatin Ascend Laboratories
  • Greece · Cildar Plus, Ezetimib/Simvastatin Mylan
  • Croatia · Inegy, Vasitimb
  • Hungary · Inegy
  • Ireland · Ezetimibe/Simvastatin Clonmel, Ezetimibe/Simvastatin Krka
  • Iceland · Ezetimib/Simvastatin Krka, Inegy
  • Italy · Ezetimibe E Simvastatina Accord, Ezetimibe E Simvastatina Almus
  • Luxembourg · Ezetimib/Simvastatin Ratiopharm®, Ezetimibe/Simvastatine Eg
  • Norway · Ezetimib/Simvastatin Glenmark, Ezetimib/Simvastatin Krka
  • Portugal · Inegy, Sinvastatina + Ezetimiba Alter
  • Sweden · Ezetimib/Simvastatin Krka, Ezetimibe/Simvastatin Accord
  • Slovenia · Inegy, Vasitimb
  • Slovakia · Cornusan, Ezetimib/Simvastatín Teva B.V.

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bab967b3-ee4d-409c-bac6-380668b43d8f
GET /v1/drugs/bab967b3-ee4d-409c-bac6-380668b43d8f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h115287_smpc.pdf",
  "strength": null,
  "atc_label": "Simvastatin And Ezetimibe",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg115287",
  "excipients": [
    "ASCORBINEZUUR (E 300)",
    "BUTYLHYDROXYANISOL (E 320)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CITROENZUUR 1-WATER (E 330)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT"
  ],
  "substances": [
    "EZETIMIB",
    "SIMVASTATINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h115287.pdf",
  "authorised_at": "2015/06/22",
  "procedure_number": "DE/H/6713/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "115287",
  "additional_monitoring": "N"
}

See everything about simvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.